These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8219665)

  • 1. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.
    Schwörer H; Ramadori G
    Clin Investig; 1993 Aug; 71(8):659-62. PubMed ID: 8219665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.
    Schwörer H; Hartmann H; Ramadori G
    Pain; 1995 Apr; 61(1):33-37. PubMed ID: 7644246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.
    Weisshaar E; Dunker N; Röhl FW; Gollnick H
    Exp Dermatol; 2004 May; 13(5):298-304. PubMed ID: 15140020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy.
    Weisshaar E; Dunker N; Domröse U; Neumann KH; Gollnick H
    Clin Nephrol; 2003 Feb; 59(2):124-9. PubMed ID: 12608555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
    Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
    Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review.
    To TH; Clark K; Lam L; Shelby-James T; Currow DC
    J Pain Symptom Manage; 2012 Nov; 44(5):725-30. PubMed ID: 22727254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of ondansetron in the pruritus of cholestasis.
    O'Donohue JW; Pereira SP; Ashdown AC; Haigh CG; Wilkinson JR; Williams R
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1041-5. PubMed ID: 15813840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron therapy for uremic pruritus in hemodialysis patients.
    Ashmore SD; Jones CH; Newstead CG; Daly MJ; Chrystyn H
    Am J Kidney Dis; 2000 May; 35(5):827-31. PubMed ID: 10793015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.
    Müller C; Pongratz S; Pidlich J; Penner E; Kaider A; Schemper M; Raderer M; Scheithauer W; Ferenci P
    Eur J Gastroenterol Hepatol; 1998 Oct; 10(10):865-70. PubMed ID: 9831410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ondansetron and pruritus in chronic liver disease: a controlled study.
    Jones EA; Molenaar HA; Oosting J
    Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron for pruritus in child with chronic cholestasis.
    Trioche P; Samuel D; Odièvre M; Labrune P
    Eur J Pediatr; 1996 Nov; 155(11):990. PubMed ID: 8911904
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron.
    Di Martino M; Galanti B; Nardiello S
    Ital J Gastroenterol; 1995; 27(8):455. PubMed ID: 8775475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ondansetron for cholestatic pruritus].
    Lamelo Alfonsín F; Vila Arias M; San Martín Moreira J; Silva César M
    An Med Interna; 1998 Aug; 15(8):456. PubMed ID: 9780438
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron].
    Zenker S; Schuh T; Degitz K
    J Dtsch Dermatol Ges; 2003 Sep; 1(9):705-10. PubMed ID: 16285277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of opioid-induced pruritus with ondansetron: report of four patients.
    Larijani GE; Goldberg ME; Rogers KH
    Pharmacotherapy; 1996; 16(5):958-60. PubMed ID: 8888093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5HT3 receptor antagonists and pruritus due to cholestasis.
    Quigley C
    Palliat Med; 1996 Jan; 10(1):54. PubMed ID: 8821191
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of opioid-induced pruritus: a role for 5-HT3 antagonists?
    Kyriakides K; Hussain SK; Hobbs GJ
    Br J Anaesth; 1999 Mar; 82(3):439-41. PubMed ID: 10434832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
    Schwörer H; Ramadori G
    Z Gastroenterol; 1995 May; 33(5):265-74. PubMed ID: 7610695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch.
    Murphy M; Reaich D; Pai P; Finn P; Carmichael AJ
    Br J Dermatol; 2003 Feb; 148(2):314-7. PubMed ID: 12588385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron for paediatric uraemic pruritus: a case report.
    Deshpande PV
    Pediatr Nephrol; 2004 Jun; 19(6):694-6. PubMed ID: 15085422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.